Biodegradable polymeric nanoparticles as drug delivery devices.

This review presents the most outstanding contributions in the field of biodegradable polymeric nanoparticles used as drug delivery systems. Methods of preparation, drug loading and drug release are covered. The most important findings on surface modification methods as well as surface characterization are covered from 1990 through mid-2000.

[1]  J. Benoit,et al.  End-chain radiolabeling and in vitro stability studies of radiolabeled poly(hydroxy acid) nanoparticles. , 1994, Journal of pharmaceutical sciences.

[2]  G. Cavallaro,et al.  Pefloxacine mesilate- and ofloxacin-loaded polyethylcyanoacrylate nanoparticles: characterization of the colloidal drug carrier formulation. , 1995, Journal of pharmaceutical sciences.

[3]  R. Gurny,et al.  Preparation of aqueous polymeric nanodispersions by a reversible salting-out process : influence of process parameters on particle size , 1992 .

[4]  J. U. Park,et al.  Simple preparation of nanoparticles coated with carbohydrate-carrying polymers. , 1997, Biomaterials.

[5]  H. Fessi,et al.  Primaquine-loaded poly(lactide) nanoparticles : physicochemical study and acute tolerance in mice , 1995 .

[6]  M. Radwan.  In Vitro Evaluation of Polyisobutylcyanoacrylate Nanoparticles as a Controlled Drug Carrier for Theophylline , 1995 .

[7]  J. Kreuter,et al.  Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants , 1990 .

[8]  M. Groves,et al.  Formulation and Biological Activity of Antineoplastic Proteoglycans Derived from Mycobacterium vaccae in Chitosan Nanoparticles , 1999, The Journal of pharmacy and pharmacology.

[9]  H Fessi,et al.  Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. , 1998, Journal of microencapsulation.

[10]  D. Ranney.  Biomimetic transport and rational drug delivery. , 2000, Biochemical pharmacology.

[11]  J. Poupaert,et al.  Development of poly (dialkyl methylidenemalonate) nanoparticles as drug carriers , 1993 .

[12]  T. Kissel,et al.  Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[13]  S. Davis,et al.  The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338) , 1984, FEBS letters.

[14]  P. Couvreur,et al.  [Perspective on the use of microdisperse forms as intracellular vehicles]. , 1978, Pharmaceutica acta Helvetiae.

[15]  K. Johnston,et al.  Microencapsulation of proteins by rapid expansion of supercritical solution with a nonsolvent , 2000 .

[16]  P Couvreur,et al.  Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum. , 1979, Journal of pharmaceutical sciences.

[17]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[18]  R. Müller,et al.  The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908. , 1987, Life sciences.

[19]  F. Leonard.  CHAPTER 11 – HEMOSTATIC APPLICATIONS OF ALPHA CYANOACRYLATES: BONDING MECHANISM AND PHYSIOLOGICAL DEGRADATION OF BONDS , 1970 .

[20]  Lisa Brannon-Peppas,et al.  Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery , 1995 .

[21]  Jean W. Tom,et al.  Formation of Bioerodible Polymeric Microspheres and Microparticles by Rapid Expansion of Supercritical Solutions , 1991, Biotechnology progress.

[22]  Young Moo Lee,et al.  Poly(ethylene oxide)–poly(propylene oxide)–poly(ethylene oxide) (Pluronic)/poly(ε-caprolactone) (PCL) amphiphilic block copolymeric nanospheres: I. Preparation and characterization , 1999 .

[23]  P Couvreur,et al.  Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. , 1999, Biomaterials.

[24]  M. Lück,et al.  Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Y. M. Lee,et al.  Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and DL-lactide block copolymer as novel drug carriers. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[26]  D. Bazile,et al.  Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. , 1995, Journal of pharmaceutical sciences.

[27]  L. Brannon-Peppas,et al.  Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[28]  V. Calhoun,et al.  Controlled release of bioactive materials. , 1980 .

[29]  A. Maruyama,et al.  Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid). , 1997, Bioconjugate chemistry.

[30]  P Couvreur,et al.  Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. , 1997, Life sciences.

[31]  E. Mathiowitz,et al.  Nanosphere based oral insulin delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[32]  C Vigneron,et al.  Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[33]  F. Veronese,et al.  Stabilization of substances in circulation. , 1998, Bioconjugate chemistry.

[34]  Yoshiaki,et al.  Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. , 1993 .

[35]  Andreas Zimmer,et al.  Microspheres and nanoparticles used in ocular delivery systems , 1995 .

[36]  M. Alonso,et al.  Approaches to improve the association of amikacin sulphate to poly(alkylcyanoacrylate) nanoparticles , 1991 .

[37]  A. Schindler,et al.  Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters. , 1979, Journal of pharmaceutical sciences.

[38]  N. Wang,et al.  A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery. , 1997, Journal of pharmaceutical sciences.

[39]  G. Gregoriadis.  Drug carriers in biology and medicine , 1979 .

[40]  P. Couvreur,et al.  Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol). , 1997, Journal of biomedical materials research.

[41]  Tae Gwan Park,et al.  Preparation of porous and nonporous biodegradable polymeric hollow microspheres , 1995 .

[42]  R. Manly.  Adhesion in biological systems. , 1967, Science.

[43]  S. Benita,et al.  A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure , 1993 .

[44]  T Görner,et al.  Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[45]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[46]  T. Uchida,et al.  Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. , 1996, Chemical & pharmaceutical bulletin.

[47]  R. Müller,et al.  Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908 , 1993 .

[48]  Rainer H. Müller,et al.  Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length , 1992 .

[49]  M. Boroujerdi,et al.  Investigation of the relative affinity of doxorubicin for neutral and negatively charged particulate carriers , 1993 .

[50]  P. Couvreur,et al.  Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[51]  R. Müller,et al.  Adsorption of ethoxylated surfactants on nanoparticles. I. Characterization by hydrophobic interaction chromatography , 1991 .

[52]  Simon Benita,et al.  The influence of process parameters on the PLA nanoparticle size distribution, evaluated by means of factorial design , 1995 .

[53]  D. A. Kharkevich,et al.  Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles , 1995 .

[54]  Robert Langer,et al.  PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics1 , 1997 .

[55]  Lu Ze,et al.  A method for the preparation of polymeric nanocapsules without stabilizer. , 1999 .

[56]  J. Kreuter,et al.  Colloidal Drug Delivery Systems , 1994 .

[57]  D. Bazile,et al.  Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. , 1996, Biomaterials.

[58]  D. Begley,et al.  Saturable mechanism for delta sleep-inducing peptide (DSIP) at the blood-brain barrier of the vascularly perfused guinea pig brain , 1989, Peptides.

[59]  J. Poupaert,et al.  Poly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice. , 1991, Journal of pharmaceutical sciences.

[60]  M. Alonso,et al.  Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers , 1997 .

[61]  M A Egea,et al.  Entrapment of cisplatin into biodegradable polyalkylcyanoacrylate nanoparticles. , 1994, Farmaco.

[62]  R. Gurny,et al.  New approach for the preparation of nanoparticles by an emulsification-diffusion method , 1995 .

[63]  V. Torchilin.  Polymer-coated long-circulating microparticulate pharmaceuticals. , 1998, Journal of microencapsulation.

[64]  C. J. Oss,et al.  Phagocytosis as a Surface Phenomenon , 1978 .

[65]  S. Kagatani,et al.  Nanosphere Coated with Lactosyl-Polystyrene Polymer as a Targeting Carrier to Hepatocytes , 1999 .

[66]  S. Davis,et al.  Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration. , 1983, Journal of pharmaceutical sciences.

[67]  Patrick Couvreur,et al.  Controlled drug delivery with nanoparticles : current possibilities and future trends , 1995 .

[68]  P. Couvreur,et al.  Nano- and microparticles for the delivery of polypeptides and proteins , 1993 .

[69]  G. Cavallaro,et al.  Entrapment of β-lactams antibiotics in polyethylcyanoacrylate nanoparticles: Studies on the possible in vivo application of this colloidal delivery system , 1994 .

[70]  C Washington,et al.  Drug release from microdisperse systems: a critical review , 1990 .

[71]  R. Arshady.  Preparation of biodegradable microspheres and microcapsules: 2. Polyactides and related polyesters , 1991 .

[72]  K. Johnston,et al.  Formation of poly(1,1,2,2-tetrahydroperfluorodecyl acrylate) submicron fibers and particles from supercritical carbon dioxide solutions , 1995 .

[73]  B. Sabel,et al.  Nanoparticle technology for delivery of drugs across the blood-brain barrier. , 1998, Journal of pharmaceutical sciences.

[74]  M. Alonso,et al.  Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[75]  Jean W. Tom,et al.  Precipitation of poly(l-lactic acid) and composite poly(l-lactic acid)-pyrene particles by rapid expansion of supercritical solutions , 1994 .

[76]  M. Alonso.  Nanoparticulate Drug Carrier Technology , 1996 .

[77]  D. Wise,et al.  POLYLACTIC ACID AS A BIODEGRADABLE CARRIER FOR CONTRACEPTIVE STEROIDS , 1973 .

[78]  M. Groves,et al.  Gelatin Behaviour in Dilute Aqueous Solution: Designing a Nanoparticulate Formulation , 1999, The Journal of pharmacy and pharmacology.

[79]  I. Fishbein,et al.  Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[80]  R. K. Kulkarni,et al.  The degradation of n-butyl alpha-cyanoacrylate tissue adhesive. II. , 1968, Surgery.

[81]  R. Jalil,et al.  Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. , 1990, Journal of microencapsulation.

[82]  D. Wise,et al.  An injectable sustained release fertility control system. , 1976, Contraception.

[83]  S. Yeung,et al.  Sub‐Micrometer‐Sized Biodegradable Particles of Poly(L‐Lactic Acid) via the Gas Antisolvent Spray Precipitation Process , 1993, Biotechnology progress.

[84]  G. Ponchel,et al.  Cyclodextrins and carrier systems. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[85]  M. El-Samaligy,et al.  Polyalkyl cyanoacrylate nanocapsules , 1986, The Journal of pharmacy and pharmacology.

[86]  D. Hochstrasser,et al.  Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting , 1996 .

[87]  C. G. Knight.  Liposomes, from physical structure to therapeutic applications , 1981 .

[88]  K. Shakesheff,et al.  Polymeric systems for controlled drug release. , 1999, Chemical reviews.

[89]  J. Poupaert,et al.  Synthesis of C-14-labeled Acrylic Derivatives - Diethyl [3-c-14] Methylidenemalonate and Isobutyl [3-c-14] Cyanoacrylate , 1989 .

[90]  M. Ueda,et al.  Influence of the preparation methods on the drug release behaviour of loperamide-loaded nanoparticles. , 1998, Journal of microencapsulation.

[91]  S. Benita,et al.  Nanoparticle characterization : a comprehensive physicochemical approach , 1991 .

[92]  R. Müller,et al.  In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. III. Uptake of differently sized surface-modified particles, and its correlation to particle properties and in vivo distribution , 1993 .

[93]  Robert Gurny,et al.  Drug-loaded nanoparticles : preparation methods and drug targeting issues , 1993 .

[94]  Bernhard A. Sabel,et al.  Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections , 1996, Brain Research.

[95]  K. Audus,et al.  Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers , 1994 .

[96]  H. Takeuchi,et al.  Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[97]  P. Couvreur,et al.  Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties , 1979, The Journal of pharmacy and pharmacology.

[98]  Gert Storm,et al.  Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .

[99]  W. Semmler,et al.  The influence of the sample preparation on plasma protein adsorption patterns on polysaccharide-stabilized iron oxide particles and N-terminal microsequencing of unknown proteins. , 1997, Journal of drug targeting.

[100]  M. Alonso,et al.  Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. , 1996, Journal of pharmaceutical sciences.

[101]  S. Benita,et al.  Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model , 1990 .

[102]  Joseph D. Andrade,et al.  Protein—surface interactions in the presence of polyethylene oxide , 1991 .

[103]  B. Sabel,et al.  Efficacy of Oral Dalargin-loaded Nanoparticle Delivery across the Blood–Brain Barrier , 1998, Peptides.

[104]  R. Langer,et al.  Biomaterials in drug delivery and tissue engineering: one laboratory's experience. , 2000, Accounts of chemical research.

[105]  P. Couvreur,et al.  New Poly(Methylidene Malonate 2.1.2) Nanoparticles: Recent Developments , 1994 .

[106]  C. Roques-carmes,et al.  Physico-chemical characterization, preparation and performance of poly (methylidene malonate 2.1.2) nanoparticles. , 1998, Biomaterials.

[107]  Jean W. Tom,et al.  Particle formation with supercritical fluids—a review , 1991 .

[108]  T. Gray,et al.  A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats. , 1997, Clinical science.

[109]  A. Schindler,et al.  Biodegradable drug delivery systems based on aliphatic polyesters: application to contraceptives and narcotic antagonists. , 1981, NIDA research monograph.

[110]  D. A. Kharkevich,et al.  Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. , 1998, Journal of microencapsulation.

[111]  R. Bodmeier,et al.  Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method , 1988 .

[112]  K. Audus,et al.  In‐vitro Characterization of Blood‐brain Barrier Permeability to Delta Sleep‐inducing Peptide , 1989, The Journal of pharmacy and pharmacology.

[113]  L. Balant,et al.  Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement. , 1997, Journal of biomedical materials research.

[114]  A. Coombes,et al.  The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery , 1993 .